Hemi Ventures, Llc — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Persephone Biosciencespersephonebiosciences.cominFeb 2021
Persephone Biosciences develops a synbiotic (probiotic and prebiotic combination) supplement for infants designed to replenish key beneficial gut bacteria.
BiotechFemTechHealthtechSan Diego, US
Stephanie Culler(Founder/CEO)inStephen Van Dien(Founder/CTO)in
PartnerAmy Gu· solo GP
Co-investorsBioBritFifty YearsFirst Bight VenturesOcampo CapitalY CombinatorDCVC (Data Collective)+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.